Diabetes and Obesity: What is New in 2025

Dear Colleagues,

The incidence and prevalence of both type 1 and type 2 diabetes are increasing in all communities across the globe. This alarming trend is in concert with the rapid rise in the prevalence of overweight and obesity. The latter can be attributed to changes in lifestyle that encompass high-calorie diets and reduced physical activity. Since these two disorders are so closely intertwined, they have been christened with a new name: “diabesity”. Concomitantly, a clustering of both traditional and novel cardiovascular risk factors is threatening the metabolic health of communities worldwide. With insulin resistance at its core, the so-called “metabolic syndrome” has emerged as a manifestation of hyperglycemia, hypertension, dyslipidemia, and central body fat deposition. The presence of this pathologic condition leads to an elevated risk of both type 2 diabetes and cardiovascular disease. These interrelated non-communicable “cardioglucometabolic” disorders have supplanted infectious diseases as the new and predominant threats to human health.

This Special Issue of the journal Medicina is intended to address new challenges and solicit emerging knowledge in the arena of diabetes and obesity. Its objective is to elicit research submissions that are relevant, innovative, and impactful. The scope of this Special Issue covers all basic and clinical topics that enhance our understanding and clinical applicability of cutting-edge findings leading to state-of-the-art therapeutic approaches. As Guest Editors, we welcome your valuable work ranging from basic cellular–molecular concepts to advancements in public health and pharmacotherapeutic interventions. We look forward to you joining us in a mutual endeavor to provide an avenue for the encouragement and dissemination of important and timely knowledge related to diabetes and obesity in the scientific community.

Prof. Dr. Manfredi Rizzo
Dr. Ali Abbas Rizvi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• diabetes
• obesity
• metabolic syndrome
• cardiovascular disease
• insulin resistance